PublicationsIndexed Publications1. Venkatesan K, Anand V, Bajpai R, Kabre RS, Kapadia A, Almel S, et al. A single-institutionretrospective analysis of outcomes for locally advanced rectal cancer treated with neoadjuvantchemoradiotherapy. J Radiat Cancer Res 2020;11:81-9.2. Gupta PK, Lal P, Bajpai R, Goel A, Yadav R, Verma M, Kumar S. Long term results ofcomparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with sixfractions per week radiotherapy in locally advanced head neck cancer. South Asian J Cancer. 2016Apr-Jun;5(2):80-4.3. Kannan V, Bajpai R. Conforming Modern Radiation Oncology Facilities to the Irregular Contoursof the Vast & Varied Nation of India. Int. J. Radiation Oncology, Biology, Physics Vol.94, No. 4,pp 645-651, 2016.4. Lal P, Bajpai R, Khurana R, Das KJ, Kumar P, Tiwari A, Gupta N, Kumar S. Changes in salivaryflow rates in head and neck cancer after chemoradiotherapy. J Cancer Res Ther. 2010 Oct-Dec;6(4):458-62.5. Agrawal S, Bajpai R, Agrawal RK, Gupta TC. Bilateral synchronous seminoma with bilateralcryptorchidism of the testis. Indian J Urol. 2010 Oct;26(4):587-9.6. Lal P, Tiwari A, Verma A, Das KJ, Baijal SS, Bajpai R, Kumar P, Srivastava A, Kumar S. Role ofvideo-fluorography in assessing functional abnormalities in patients of head and neck cancertreated with chemoradiotherapy. Asia-Pacific Journal of Clinical Oncology 2009; 5:264-269.7. Bajpai R, Srivastava A, Lal P, Kumar S. Defining the Standard of Care: Waiting Times, DataRecording, Adverse Effects Reporting, Radiotherapy Compliance and Follow-up of Head andNeck Cancer Patients, at a Tertiary Cancer Center in India. Int J. Radiation Oncology, Biology,Physics 2008; 72:S412-413.8. Tiwari A, Kumar N, Bajpai R, Lal P. Bone metastasis from ovarian cancer. Journal of CancerResearch and Therapeutics 2007; 3:34-36.Published Abstracts1. Comparison of heart and lung doses in deep inspiration breath hold radiotherapy and proneposition radiotherapy for whole breast radiation therapy. Poster #: TU_26_3149.Proceedings ASTRO 2018, San Antonio, Texas.2. Use of Portal dosimetry to monitor treatment consistency throughout the course of treatment.Poster: E36-0720. Proceedings ESTRO 2017, Vienna, Austria.3. Outcomes in Medulloblastoma: Single institution case series: Neuro-Oncology 16:V188-V196,2014. Proceedings SNO 2014, held in Miami, USA in Nov 2014.4. ‘Treatment outcome for Germ cell tumor (GCT) Brain’ – Neuro-Oncology 16:i30–i39, 2014.Proceedings ISPNO 2014, held in Singapore in June 2014.5. ‘Patterns of outcome in treatment of stomach cancer’, Indian Cancer Congress, New Delhi,India in Nov 2013.6. ‘Chemo-radiotherapy offers better quality of life and survival outcome compared to surgery inmuscle invasive bladder cancer’. RGCON, held in New Delhi, India. March 2010.7. ‘Does addition of chemotherapy or accelerated radiotherapy benefits in oral cancer lesions- aretrospective audit’”. J Oral Oncology Supplement, 2009, 3: 188-89. Poster presented atSecond World Congress of the International Academic of Oral Oncology in July 2009.8. ‘The standard of care: waiting times, data recording, adverse effects reporting, radiotherapycompliance, and follow-up of head & neck cancer patients, at a tertiary cancer center in India’.ASTRO Annual Meeting, held in Boston, USA September 2008.9. ‘Does the use of Percutaneous Endoscopic Gastrostomy (Peg) improve compliance to intensiveChemo-Radiotherapy’. (Crt) Protocols in Advanced Head-Neck Cancers”. World CancerCongress, UICC, held in Washington DC, 2006.10. ‘Six fractions a-week radiotherapy along with concurrent weekly cisplatin in locally advancedhead and neck cancer’. ESTRO meeting 2006.11. ‘Changes in basal and stimulated salivary flow rates in patients of head and neck cancertreated with conventional radiotherapy techniques. ESTRO meeting 2006 (Co-author in thestudy).12. ‘Role of Percutaneous Endoscopic Gastrostomy for enteral nutrition in patients with head andneck cancers on intensive chemo-radiation protocols - A feasibility study’. Annual Conferenceof the Association of Radiation Oncologists of India (AROICON 2005), held in Ahmedabad,India, December 2005.Invited TalksActively involved as Panelist/ Expert speaker at various national & international meetings.1. Invited Faculty at Year in review Breast held at Tata Memorial Centre in Jan 2024.2. Invited Faculty at Indian Cancer Congress, Mumbai in Nov 2023.3. Invited Faculty at National Liver ‘BUILD’ conference in Jan 2023 & Jan 2024.4. ‘Post-operative Prostate cancer’ at Best of ASTRO 2018-India in June 2019, Kolkata, India.5. ‘GU cancer symposium’ at Best of ASCO- India, June 2019, Mumbai, India.6. ‘Oncotype score in post-mastectomy radiotherapy’ at Best of ASTRO 2017-India in May 2018,New Delhi, India.7. Invited speaker at 12th International Conference of the Asian Clinical Oncology Society (ACOS2016) held at New Delhi in April 2016.8. ‘Current concepts in management of Low Grade Gliomas’ at ISMPO, Mumbai, 2015.9. Invited speaker for First ‘Best of ASTRO’ at KDAH, Mumbai, May 2015.10. Evaluation of 3D-CRT/IMRT for cranio-spinal irradiation in supine position’. 2nd Neuro-Oncology society of India meeting held in Chennai, India from April 2-4, 2010.11. ‘The Quality of Recording of Patient Demography; Compliance to Radiotherapy, MorbidityReporting and Status of Follow-up of Head and Neck Cancer Patients’. Annual Conference ofthe Association of Radiation Oncologists of India, UP chapter, Lucknow 2008.12. ‘Role of Percutaneous Endoscopic Gastrostomy for enteral nutrition in patients with head andneck cancers on intensive chemo-radiation protocols - A feasibility study’. Annual Conference ofthe Association of Radiation Oncologists of India (AROICON 2005), held in Ahmedabad, India,December 2005.
Best Hospital Near me Chennai